Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome

Ning Xu, Kent D. Taylor, Ricardo Azziz, Mark O. Goodarzi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To study the role of genetic variation in the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR) gene in polycystic ovary syndrome (PCOS). Design: Women with and without PCOS were genotyped for seven single-nucleotide polymorphisms (SNPs) in HMGCR. The SNPs and haplotypes were determined and tested for association with PCOS and its component traits. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; control subjects were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Patient(s): A total of 287 white PCOS women and 187 control subjects were studied. Intervention(s): Phenotypic and genotypic assessment. Main Outcome Measure(s): HMGCR genotype, PCOS diagnosis, androgen levels, metabolic traits. Result(s): No association with PCOS was observed. SNP rs4629571 was associated with increased insulin resistance. Haplotype 3 was associated with increased insulin resistance. Haplotype 5 was associated with higher SHBG and lower free T. Conclusion(s): Variation in the HMGCR gene may influence component features of PCOS, including insulin resistance, SHBG, and free T. HMGCR may thus act as a modifier gene in PCOS.

Original languageEnglish (US)
JournalFertility and sterility
Volume94
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Gene Components
Polycystic Ovary Syndrome
Coenzyme A
Oxidoreductases
Phenotype
Hydroxymethylglutaryl CoA Reductases
Haplotypes
Single Nucleotide Polymorphism
Insulin Resistance
Modifier Genes
Los Angeles
Endocrinology
Androgens
Genes
Genotype
Outcome Assessment (Health Care)

Keywords

  • HMGCR
  • Polycystic ovary syndrome
  • SHBG
  • androgens
  • insulin resistance

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. / Xu, Ning; Taylor, Kent D.; Azziz, Ricardo; Goodarzi, Mark O.

In: Fertility and sterility, Vol. 94, No. 1, 01.01.2010.

Research output: Contribution to journalArticle

Xu, Ning ; Taylor, Kent D. ; Azziz, Ricardo ; Goodarzi, Mark O. / Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. In: Fertility and sterility. 2010 ; Vol. 94, No. 1.
@article{73648eb5c5dc41809a338b0d19c22dbd,
title = "Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome",
abstract = "Objective: To study the role of genetic variation in the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR) gene in polycystic ovary syndrome (PCOS). Design: Women with and without PCOS were genotyped for seven single-nucleotide polymorphisms (SNPs) in HMGCR. The SNPs and haplotypes were determined and tested for association with PCOS and its component traits. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; control subjects were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Patient(s): A total of 287 white PCOS women and 187 control subjects were studied. Intervention(s): Phenotypic and genotypic assessment. Main Outcome Measure(s): HMGCR genotype, PCOS diagnosis, androgen levels, metabolic traits. Result(s): No association with PCOS was observed. SNP rs4629571 was associated with increased insulin resistance. Haplotype 3 was associated with increased insulin resistance. Haplotype 5 was associated with higher SHBG and lower free T. Conclusion(s): Variation in the HMGCR gene may influence component features of PCOS, including insulin resistance, SHBG, and free T. HMGCR may thus act as a modifier gene in PCOS.",
keywords = "HMGCR, Polycystic ovary syndrome, SHBG, androgens, insulin resistance",
author = "Ning Xu and Taylor, {Kent D.} and Ricardo Azziz and Goodarzi, {Mark O.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.fertnstert.2009.01.158",
language = "English (US)",
volume = "94",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome

AU - Xu, Ning

AU - Taylor, Kent D.

AU - Azziz, Ricardo

AU - Goodarzi, Mark O.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Objective: To study the role of genetic variation in the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR) gene in polycystic ovary syndrome (PCOS). Design: Women with and without PCOS were genotyped for seven single-nucleotide polymorphisms (SNPs) in HMGCR. The SNPs and haplotypes were determined and tested for association with PCOS and its component traits. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; control subjects were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Patient(s): A total of 287 white PCOS women and 187 control subjects were studied. Intervention(s): Phenotypic and genotypic assessment. Main Outcome Measure(s): HMGCR genotype, PCOS diagnosis, androgen levels, metabolic traits. Result(s): No association with PCOS was observed. SNP rs4629571 was associated with increased insulin resistance. Haplotype 3 was associated with increased insulin resistance. Haplotype 5 was associated with higher SHBG and lower free T. Conclusion(s): Variation in the HMGCR gene may influence component features of PCOS, including insulin resistance, SHBG, and free T. HMGCR may thus act as a modifier gene in PCOS.

AB - Objective: To study the role of genetic variation in the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR) gene in polycystic ovary syndrome (PCOS). Design: Women with and without PCOS were genotyped for seven single-nucleotide polymorphisms (SNPs) in HMGCR. The SNPs and haplotypes were determined and tested for association with PCOS and its component traits. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; control subjects were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Patient(s): A total of 287 white PCOS women and 187 control subjects were studied. Intervention(s): Phenotypic and genotypic assessment. Main Outcome Measure(s): HMGCR genotype, PCOS diagnosis, androgen levels, metabolic traits. Result(s): No association with PCOS was observed. SNP rs4629571 was associated with increased insulin resistance. Haplotype 3 was associated with increased insulin resistance. Haplotype 5 was associated with higher SHBG and lower free T. Conclusion(s): Variation in the HMGCR gene may influence component features of PCOS, including insulin resistance, SHBG, and free T. HMGCR may thus act as a modifier gene in PCOS.

KW - HMGCR

KW - Polycystic ovary syndrome

KW - SHBG

KW - androgens

KW - insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=77952544995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952544995&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2009.01.158

DO - 10.1016/j.fertnstert.2009.01.158

M3 - Article

C2 - 19327767

AN - SCOPUS:77952544995

VL - 94

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -